Skip to main content
Erschienen in: Urolithiasis 3/2013

01.06.2013 | Original Paper

Stone expulsion rate of small distal ureteric calculi could be predicted with plasma C-reactive protein

verfasst von: Hussein A. Aldaqadossi

Erschienen in: Urolithiasis | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Ureteral stones tend to induce inflammatory lesions in the ureteric wall; such lesions may interfere with the probability of spontaneous ureteral stone passage. Plasma C-reactive protein (CRP) is an acute-phase protein whose serum level is increases in response to inflammation, as in ureteric inflammatory disorders induced by stone impaction. Patients with distal ureteric stones were included in this study. All patients were subjected to history taking KUB, urinary tract ultrasound, Non-contrast CT (NC-CTKUB) scan, and plasma CRP estimation. All patients received medical expulsive therapy. Patients were examined weekly using KUB and urinary tract ultrasound until spontaneous stone passage or intervention after 4 weeks. Patients who failed to expel the stone within 4 weeks underwent ureteroscopy. Spontaneous stone expulsion within 4 weeks was recorded in 129 patients (54.9 %), while 106 patients (45.1 %) underwent ureteroscopy for stone extraction. Patients with spontaneous stone expulsion had significantly lower serum CRP levels (16.45 + 2.58) than those who failed to pass the stone spontaneously (39.67 + 6.30). Receiver operator characteristic curve is used to determine CRP cut-off point for prediction of spontaneous ureteric stone expulsion. A cut-off point of 21.9 mg/L for CRP yielded appeared optimal for prediction of spontaneous ureteric stone expulsion. Medical expulsive therapy success for management of small distal ureteric calculi could be predicted with plasma CRP. Patients with CRP >21.9 mg/L have low stone expulsion rate and should directly be subjected for an immediate, minimally invasive ureteroscopy.
Literatur
1.
Zurück zum Zitat Gravas S, Tzortzis V, Karatzas A et al (2007) The use of tamsulosin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 35:231PubMedCrossRef Gravas S, Tzortzis V, Karatzas A et al (2007) The use of tamsulosin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 35:231PubMedCrossRef
2.
Zurück zum Zitat Lotan Y, Gettman MT, Roehrborn CG et al (2002) Management of ureteral calculi: a cost comparison and decision making analysis. J Urol 167:1621PubMedCrossRef Lotan Y, Gettman MT, Roehrborn CG et al (2002) Management of ureteral calculi: a cost comparison and decision making analysis. J Urol 167:1621PubMedCrossRef
3.
Zurück zum Zitat Hubner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. EurUrol 24:172 Hubner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. EurUrol 24:172
4.
Zurück zum Zitat Ueno A, Kawamura T, Ogawa A et al (1977) Relation of spontaneous passage of ureteral calculi to size. Urology 10:544PubMedCrossRef Ueno A, Kawamura T, Ogawa A et al (1977) Relation of spontaneous passage of ureteral calculi to size. Urology 10:544PubMedCrossRef
5.
Zurück zum Zitat Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101PubMedCrossRef Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101PubMedCrossRef
6.
Zurück zum Zitat Cervenakov I, Fillo J, Mardiak J et al (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1 blockers—tamsulosin. Int J Urol Nephrol 34:25CrossRef Cervenakov I, Fillo J, Mardiak J et al (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1 blockers—tamsulosin. Int J Urol Nephrol 34:25CrossRef
7.
Zurück zum Zitat Preminger GM, Tiselius H-G, Assimos DG, From the American Urological Association Education and Research, Inc., European Association of Urology et al (2007) 2007 guideline for the management of ureteral calculi. Eur Urol 2007(52):1610CrossRef Preminger GM, Tiselius H-G, Assimos DG, From the American Urological Association Education and Research, Inc., European Association of Urology et al (2007) 2007 guideline for the management of ureteral calculi. Eur Urol 2007(52):1610CrossRef
8.
Zurück zum Zitat Miller OF, Kane CJ (1999) Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 162:688–690PubMedCrossRef Miller OF, Kane CJ (1999) Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 162:688–690PubMedCrossRef
9.
Zurück zum Zitat Segura JW, Preminger GM, Assimos DG et al (1997) Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 158:1915–1921PubMedCrossRef Segura JW, Preminger GM, Assimos DG et al (1997) Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 158:1915–1921PubMedCrossRef
10.
Zurück zum Zitat Ibrahim AIA, Shetty SD, Awad RM, Patel KP (1991) Prognostic factors in the conservative treatment of ureteric stones. Br J Urol 67:358PubMedCrossRef Ibrahim AIA, Shetty SD, Awad RM, Patel KP (1991) Prognostic factors in the conservative treatment of ureteric stones. Br J Urol 67:358PubMedCrossRef
11.
Zurück zum Zitat Yamaguchi K, Minei S, Yamazaki T et al (1999) Characterization of ureteral lesions associated with impacted stones. Int J Urol 6:281PubMedCrossRef Yamaguchi K, Minei S, Yamazaki T et al (1999) Characterization of ureteral lesions associated with impacted stones. Int J Urol 6:281PubMedCrossRef
12.
Zurück zum Zitat Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7(2):169–177PubMedCrossRef Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7(2):169–177PubMedCrossRef
13.
Zurück zum Zitat Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed
14.
Zurück zum Zitat Horcajada JP, Velasco M, Filella X et al (2004) Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute Pyelonephritis caused by Escherichia coli. Clin Diagn Lab Immunol 11:142–146PubMed Horcajada JP, Velasco M, Filella X et al (2004) Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute Pyelonephritis caused by Escherichia coli. Clin Diagn Lab Immunol 11:142–146PubMed
15.
Zurück zum Zitat Pulliam PN, Attia MW, Cronan KM (2001) C-reactive protein in febrile children aged one to thirty-six months, with clinically undetectable serious bacterial infection. Pediatrics 108:1275–1279PubMedCrossRef Pulliam PN, Attia MW, Cronan KM (2001) C-reactive protein in febrile children aged one to thirty-six months, with clinically undetectable serious bacterial infection. Pediatrics 108:1275–1279PubMedCrossRef
16.
Zurück zum Zitat Soylu A, Kasap B, Demir K et al (2007) Predictive value of clinical and laboratory variables for vesicoureteral reflux in children. Pediatr Nephrol 22:844–848PubMedCrossRef Soylu A, Kasap B, Demir K et al (2007) Predictive value of clinical and laboratory variables for vesicoureteral reflux in children. Pediatr Nephrol 22:844–848PubMedCrossRef
17.
Zurück zum Zitat Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202PubMedCrossRef Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202PubMedCrossRef
18.
Zurück zum Zitat Porpiglia F, Destefanis P, Fiori C, Fontana D (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureteral stones. Urology 56:579PubMedCrossRef Porpiglia F, Destefanis P, Fiori C, Fontana D (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureteral stones. Urology 56:579PubMedCrossRef
19.
Zurück zum Zitat Paajanen H, Tainio H, Laato M (1996) A chance of misdiagnosis between acute appendicitis and renal colic. Scand J Urol Nephrol 30:363–366PubMedCrossRef Paajanen H, Tainio H, Laato M (1996) A chance of misdiagnosis between acute appendicitis and renal colic. Scand J Urol Nephrol 30:363–366PubMedCrossRef
20.
Zurück zum Zitat Sandberg T, Lidin-Janson G, Edén CS (1989) Host response in women with symptomatic urinary tract infection. Scand J Infect Dis 21:67–73PubMedCrossRef Sandberg T, Lidin-Janson G, Edén CS (1989) Host response in women with symptomatic urinary tract infection. Scand J Infect Dis 21:67–73PubMedCrossRef
21.
Zurück zum Zitat Yilmaz E, Batislam E, Tuglu D et al (2003) C-reactive protein in early detection of bacteremia and bacteriuria after extracorporeal shock wave lithotripsy. Eur Urol 43:270–274PubMedCrossRef Yilmaz E, Batislam E, Tuglu D et al (2003) C-reactive protein in early detection of bacteremia and bacteriuria after extracorporeal shock wave lithotripsy. Eur Urol 43:270–274PubMedCrossRef
22.
Zurück zum Zitat Shaoul R, Lahad A, Tamir A et al (2008) C-reactive protein (CRP) as a predictor for true bacteremia in children. Med Sci Monit 14:CR255–CR261PubMed Shaoul R, Lahad A, Tamir A et al (2008) C-reactive protein (CRP) as a predictor for true bacteremia in children. Med Sci Monit 14:CR255–CR261PubMed
23.
Zurück zum Zitat Bleeker SE, Derksen-Lubsen G, Grobbee DE et al (2007) Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr 96:100–104PubMedCrossRef Bleeker SE, Derksen-Lubsen G, Grobbee DE et al (2007) Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr 96:100–104PubMedCrossRef
24.
Zurück zum Zitat Angulo JC, Gaspar MJ, Rodríguez N, García-Tello A, Torres G, Núñez C (2010) The value of C-reactive protein determination in patients with renal colic to decide urgent urinary diversion. Urology 76(2):301–306PubMedCrossRef Angulo JC, Gaspar MJ, Rodríguez N, García-Tello A, Torres G, Núñez C (2010) The value of C-reactive protein determination in patients with renal colic to decide urgent urinary diversion. Urology 76(2):301–306PubMedCrossRef
25.
Zurück zum Zitat Liao CH, Chung SD, Kuo HC (2011) Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. Urology 78(6):1373–1379PubMedCrossRef Liao CH, Chung SD, Kuo HC (2011) Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. Urology 78(6):1373–1379PubMedCrossRef
Metadaten
Titel
Stone expulsion rate of small distal ureteric calculi could be predicted with plasma C-reactive protein
verfasst von
Hussein A. Aldaqadossi
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 3/2013
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0551-1

Weitere Artikel der Ausgabe 3/2013

Urolithiasis 3/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.